Applying Spatial Multiomics to Degenerative Diseases and Cancer
MALDI mass spectrometry imaging has emerged as a powerful technology platform for spatially resolved analysis and visualization of a wide range of molecules – including drugs, metabolites, peptides and more – in pharmaceutical R&D, clinical research and basic science. Advances in MALDI workflows are making the technique more accessible.
In this webinar, our speaker will discuss how new MALDI workflows can be used to analyze lipids in degenerative disease and Alzheimer’s models, providing more depth to lipid analysis and contextualizing lipid distribution by enabling comparison to multiple protein markers. He’ll also highlight how the new workflow can be applied to the study of tumor subtypes and the tumor microenvironment.
Attend this webinar to:
- Explore the multiomics applications of spatial mass spectrometry – from cancer research to understanding neurodegeneration
- Discover how MALDI mass spectrometry imaging is becoming more accessible
- Learn how to apply the simplified MALDI imaging workflow to your research
Presenter: Prof. Dr. Carsten Hopf (Head of the Center of Mass Spectrometry and Optical Spectroscopy at Mannheim Technical University)
Carsten Hopf obtained his PhD in biochemistry from Tübingen University/Max-Planck-Institute for Developmental Biology. As an EMBO fellow in neuroscience, he then worked at the Johns Hopkins University School of Medicine for three years, before joining Cellzome AG, a proteomics-focused drug discovery platform company in Heidelberg in 2001. There, for 13 years, he served in multiple roles in platform technology, assay development, drug discovery and business development, and eventually as part of Cellzome’s leadership team till 2014. Since 2005, Carsten Hopf is a professor of bioanalytics, proteomics and drug discovery at Mannheim University of Applied Sciences. He currently heads the Center of Mass Spectrometry and Optical Spectroscopy (CeMOS) as well as the M2Aind partnership for innovation in health industry in Mannheim, and he serves on boards of biomedical clusters. He is also an associated professor in the Medical and Biosciences Faculties of Heidelberg University and co-chair for “imaging” of the German Society for MS (DGMS).
